Status:
UNKNOWN
Establishment of Scoring Model for Early and Differential Diagnosis of Intrahepatic Cholangiocarcinoma
Lead Sponsor:
Qilu Hospital of Shandong University
Collaborating Sponsors:
Jinan Central Hospital
Shandong Provincial Hospital
Conditions:
Intrahepatic Cholangiocarcinoma
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to develop and validate a radiological nomogram including radiological characteristics, clinical risk factors, and medical history. And we aim to establish a noninvasive m...
Detailed Description
In recent years, the incidence and mortality of intrahepatic cholangiocarcinoma (ICC) have been increasing worldwide. Due to the different treatment options for hepatocellular carcinoma (HCC) and ICC,...
Eligibility Criteria
Inclusion
- patients with pathological confirmation of ICC or HCC,
- CT was performed less than 15 days before surgery,
- Patients with complete clinical data.
Exclusion
- history of other tumors,
- Metastatic liver cancer,
- Patients received preoperative chemotherapy or radiotherapy,
- Image quality analysis is not ideal.
Key Trial Info
Start Date :
November 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 22 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05327907
Start Date
November 22 2020
End Date
May 22 2023
Last Update
April 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology,Qilu Hospital,Shandong University
Jinan, Shandong, China, 250012